NCT00096083
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +63 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
Clinical trial condition
Carcinoma, Neuroendocrine
Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.
234 public trials
43 recruiting studies
Carcinoma, Neuroendocrine trial results
NCT00121628
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +20 more
- Locations
-
Not specified
NCT00602082
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
- Locations
-
- Basildon University Hospital Basildon, England, United Kingdom
- Addenbrooke's Hospital Cambridge, England, United Kingdom
- Cookridge Hospital Leeds, England, United Kingdom
- Leicester Royal Infirmary Leicester, England, United Kingdom
NCT00002608
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +71 more
- Locations
-
- Ottawa Regional Cancer Centre at Ottawa Hospital - General Campus Ottawa, Ontario, Canada
NCT00019331
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +88 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
NCT00027638
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +30 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00075439
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +26 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00079131
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00006368
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +105 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Completed
S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
NCT00068783
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States